Willingness-to-pay for naloxone over-the-counter and from a pharmacist

How to cite

Powell, David; Jacobson, Mireille. 2024. "Willingness-to-pay for naloxone over-the-counter and from a pharmacist." AEA RCT Registry. AEARCTR-0013657. https://doi.org/10.1257/rct.13657-1.0

Download: BibTeX · RIS — for reference managers without a browser translator. Zotero and most others pick up this page's citation metadata directly.

David Powell* , Mireille Jacobson

* Primary investigator

Registry ID
AEARCTR-0013657
DOI
https://doi.org/10.1257/rct.13657-1.0
First registered
Last updated
Status
In development
Trial dates
2024-05-23 – 2024-10-31
Countries
Private
JEL codes
I12; I18
Registry record
http://www.socialscienceregistry.org/trials/13657

Abstract

We will conduct a survey about opioid misuse and naloxone access in a nationally-representative sample and a sample that has previously stated that they suffer from opioid dependence. Within the survey, we will ask the respondents to provide their maximum willingness-to-pay for a two-dose kit of Narcan. Respondents will be randomized into one of two arms. In the first arm, the experiment will specify that the purchase will be made "from a pharmacist." In the second, they will be told that the purchase will be made "over-the-counter." We are interested in whether there are differences in the willingness-to-pay for naloxone based on where the naloxone is purchased from. We hypothesize that respondents will be willing to pay more to purchase naloxone over-the-counter to avoid interaction with a pharmacist and any associated stigma with this purchase.

Intervention

We will randomize whether respondents are asked for their willingness to pay for a two-dose kit of Narcan (a) from a pharmacist or (b) over-the-counter.

Experimental design

We are conducting the survey on Bilendi. The survey randomizes respondents into one of the two arms with a 0.5 chance of each arm.

Design details

Randomization method
Randomization done by code running the survey in real-time.
Randomization unit
Individual
Clusters
2000 respondents
Observations
2000
Arms
1000 in each treatment arm
Primary outcomes
a) We will calculate the mean willingness-to-pay for both treatment arms and compare across them. Our full sample includes a “nationally-representative sample” and an “opioid-dependent sample.” We will use the full sample. b) We will also present results for an opioid-dependent sample and for the rest of the sample. We will stratify based on our questions about opioid dependence. We will use Westfall-Young to adjust for multiple comparisons for the primary outcomes since we will present results for three (overlapping) samples.
Secondary outcomes
We will repeat the main analyses but study medians. In addition, we will make the same comparisons (means and medians) for the following stratified samples: (1) people who know someone impacted by opioids in any of the following ways: (a) struggled with an opioid addiction, (b) needed medical attention because of an opioid addiction, (c) sought treatment for an opioid addiction, (d) had an overdose (nonfatal or fatal) (e) faced police contact, arrest, or incarceration due to an opioid addiction, or (f) believe them to be likely or very likely to overdose from opioid use; (2) people who are personally impacted by opioid use (same reasons as above, although we can only include those who experienced a nonfatal overdose) or state that they are likely or very likely to overdose from opioid use. In each stratification, we will show the comparable results for the sample not meeting the conditions. (3) We will also stratify by race, gender, and political affiliation. (4) Finally, we will stratify based on the 2022 overdose death rate of the state.

Cited by

No citation data available for this registration yet.

Keywords